St Charles Prineville Laboratory

CLIA Laboratory Citation Details

2
Total Citations
6
Total Deficiencyies
4
Unique D-Tags
CMS Certification Number 38D0716183
Address 384 Se Combs Flat Road, Prineville, OR, 97754
City Prineville
State OR
Zip Code97754
Phone(541) 706-7717

Citation History (2 surveys)

Survey - July 25, 2023

Survey Type: Standard

Survey Event ID: 1UBG11

Deficiency Tags: D6032 D6103 D6032 D6103

Summary:

Summary Statement of Deficiencies D6032 LABORATORY DIRECTOR RESPONSIBILITIES CFR(s): 493.1407(e)(14) The laboratory director is responsible for the overall operation and administration of the laboratory, including the employment of personnel who are competent to perform test procedures, and record and report test results promptly, accurate, and proficiently and for assuring compliance with the applicable regulations. (e) The laboratory director must-- (e)(14) Specify, in writing, the responsibilities and duties of each consultant and each person, engaged in the performance of the preanalytic, analytic, and postanalytic phases of testing, that identifies which examinations and procedures each individual is authorized to perform, whether supervision is required for specimen processing, test performance or results reporting, and whether consultant or director review is required prior to reporting patient test results. This STANDARD is not met as evidenced by: Based on review of laboratory procedures and personnel records, the Laboratory Director (LD) failed to ensure a written document designating what each person listed as testing personnel (TP), technical supervisor (TS), technical consultant (TC) or general superviosr (GS) on the CMS 209 form is allowed to perform, train other TP to perform, assess competency in each specialty and report final results. Finding include: 1. During review of the CMS 209 forms submitted to me during survey July 25, 2023 (5 pages) and review of the competency assessments for all TP, no designation of duties by the LD could be produced. 2. The TS and the LD confirmed that no current written document desginating who could perform what test(s) and to what degree during interview on July 25, 2023 at approximately 1:30 pm. D6103 LABORATORY DIRECTOR RESPONSIBILITIES CFR(s): 493.1445(e)(13) The laboratory director must ensure that policies and procedures are established for Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- monitoring individuals who conduct preanalytical, analytical, and postanalytical phases of testing to assure that they are competent and maintain their competency to process specimens, perform test procedures and report test results promptly and proficiently, and whenever necessary, identify needs for remedial training or continuing education to improve skills. This STANDARD is not met as evidenced by: Based on review of testing personnel (TP) competency records and interview with the Technical Supervisor (TS) and Laboratory Director (LD) during survey July 25, 2023, the LD failed to ensure all TP in the Clinical Laboratory, in the Nursing Department, and in the Radiology Department had competency assessments twice a year in the first year and at least annually after the first year of employment for the testing they were performing on patient specimens. Findings include: 1. During review of TP competency records (TP # 1 - 8) in the Clinical Laboratory, composed of Medical Laboratory Technicians (MLT's) and Medical Laboratory Scientists (MLS's), it was revealed that six (6) out of eight (8) TP had no competency assessments for any testing platform or analyte they routinely perform patient testing on for the year 2022. 2. During review of TP competency records in the Clinical Laboratory (TP #1 - 6) composed of Medical Laboratory Technicians (MLT's) and Medical Laboratory Scientists (MLS's), it was revealed that five (5) out of six (6) TP had no competency assessments for any testing platform or analyte they routinely perform patient testing on for the year 2023 to date. 3. During review of the nursing personnel competency records who routinely use and report patient results using the moderately complex iSTAT instrument by Abbott Laboratories, it was revealed that seven (7) out of eight (8) Registered Nurses (RN's) had no competency assesstments for tests they routinely perform in 2022 or 2023 to date. 4. During review of the Radiology personnel who perform Creatinine testing for suspect stroke patients using the moderately complex iStat instrument by Abbott Laboratories, it was revealed that five (5) out of five (5) Radiology TP had no competency assessments for 2022 or 2023 to date. 5. Interview with the TS, TP#5 and LD conducted at approximately 1400 during survey on 07/25 /2023 confirmed that there were no competency assessments conducted in the year 2022 and 2023 to date for any of the above TP. 6. The laboratory reports performing 536,215 tests on human bodily fluid specimens in the year 2022 and 351,750 tests on human bodily fluid specimens in the year 2023 to date. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - October 4, 2021

Survey Type: Special

Survey Event ID: VE4511

Deficiency Tags: D2016 D2191

Summary:

Summary Statement of Deficiencies D2016 SUCCESSFUL PARTICIPATION CFR(s): 493.803(a)(b)(c) (a) Each laboratory performing nonwaived testing must successfully participate in a proficiency testing program approved by CMS, if applicable, as described in subpart I of this part for each specialty, subspecialty, and analyte or test in which the laboratory is certified under CLIA. (b) Except as specified in paragraph (c) of this section, if a laboratory fails to participate successfully in proficiency testing for a given specialty, subspecialty, analyte or test, as defined in this section, or fails to take remedial action when an individual fails gynecologic cytology, CMS imposes sanctions, as specified in subpart R of this part. (c) If a laboratory fails to perform successfully in a CMS- approved proficiency testing program, for the initial unsuccessful performance, CMS may direct the laboratory to undertake training of its personnel or to obtain technical assistance, or both, rather than imposing alternative or principle sanctions except when one or more of the following conditions exists: (1) There is immediate jeopardy to patient health and safety. (2) The laboratory fails to provide CMS or a CMS agent with satisfactory evidence that it has taken steps to correct the problem identified by the unsuccessful proficiency testing performance. (3) The laboratory has a poor compliance history. This CONDITION is not met as evidenced by: Review of the College of American Pathologists (CAP) proficiency testing (PT) showed the laboratory had consecutive unsuccessful participation for the 1st and 2nd event 2021 for Antibody Identification in the specialty Immunohematology . Refer to D2191. D2191 ANTIBODY IDENTIFICATION CFR(s): 493.865(f) Failure to achieve an overall testing event score of satisfactory for two consecutive Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- testing events or two out of three consecutive testing events is unsuccessful performance. This STANDARD is not met as evidenced by: Review of the College of American Pathologist (CAP) proficiency testing (PT) showed that the laboratory has unsatisfactory performance for antibody identification in the specialty Immunohematology. Finding include: 1. 1st Event 2021 - Antibody Identification - 0%. 2. 2nd Event 2021- Antibody Identification - 0%. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access